Skip to main content
. 2008 Oct 29;15(12):1868–1877. doi: 10.1128/CVI.00200-08

TABLE 3.

Results of mannanemia, antimannan antibodies, and IBDX tests in patients with invasive Candida infection

Patienta No. of available sera No. of sera in which antibody was detectedb
No. of sera with positive result by the following test:
No. of sera negative for all tests No. of tests for which patient was positive at least once (n = 5)
ASCA (50 AU) ALCA (60 AU) ACCA (80 AU) Platelia Ab Platelia Ag
7 9 0/9 2 6 8/9 1/9 0 4
1 7 4 1 7 7 3 0 5
14 7 4/7 2/7 2 5/7 0/7 1 4
18 6 0 3/6 6/6 0 4/6 0 4
6 5 3/5 1/5 0 4/5 3/5 0 4
8 5 0 0 0 3/5 2/5 0 2
4 4 4/4 0 1 4/4 2/4 0 4
17 3 2 1 3 3 0 0 4
15 3 2/3 0/3 1/3 2/3 1/3 0 4
5 3 0/3 1/3 0/3 3/3 3/3 0 3
16 3 2/3 1/3 2/3 2/3 0/3 0 4
10 2 2/2 0 1 2/2 1/2 0 4
2 2 1/2 0/2 1/2 0/2 0/2 1 2
9 2 2/2 2/2 2/2 1/2 1/2 0 5
11 2 0 0 0 0 1/2 1 1
12 2 1 1 0 1/2 0/2 1 3
13 2 1 2 2 1 0 0 4
3 2 2 0 0 0 2 0 2
a

Patients are listed according to the number of sera available (from the most to the least).

b

Number of serum samples in which antibodies at the level shown were detected. IBDX tests are ASCA, ALCA, and ACCA (the combined detection of these antibodies).